Data Points for the week of Aug. 1, 2016, covered the following topics: Health information technology deals, mergers and acquisitions; providers' IT budgets; venture capital in health IT; startup accelerators for health IT.
Shareholders at McKesson's annual meeting sided with the board and management in rejecting proposals to require greater disclosure of political contributions and limit golden parachutes for senior executives in a change of ownership.
McKesson Corp. may be weighing a separation of its information technology unit as it works to contain costs and refocus on its core drug distribution business, according to the Wall Street Journal.
The rise of high-deductible health insurance is challenging providers across the country to change the way they prepare for and collect payments from people getting hit with large out-of-pocket costs for care.
McKesson Corp. announced two deals with big-box chain Wal-Mart Stores that are expected to boost the healthcare giant after recent struggles.
Fourth-quarter and full-year earnings soared at healthcare giant McKesson Corp., mostly due to the absence of previous acquisition-related charges.
An effort to develop technology to enroll a portion of the 1 million volunteers in the White House's Precision Medicine Initiative is placing a spotlight on one possible solution to interoperability and in the meantime creating unprecedented collaboration.
McKesson Corp. is cutting its workforce by 4% or about 1,600 jobs and refining its strategy to lower costs. The plan should save the drug distributor $170 million to $190 million before taxes in fiscal 2017, as well as incremental savings of $70 million to $90 million in 2018.
Hospital systems now routinely deal with an uncomfortable number of drug shortages, so they're forging direct relationships with manufacturers, and buying directly from the source when the usual channels dry up.
One of the frustrating things about healthcare data is that they live in silos, so the user experience is far from seamless. But that's becoming unacceptable with the growth of high-deductible health plans and the corresponding wave of healthcare consumerism.
Prescription drug distributor McKesson Corp. is buying Canadian pharmacy operator Rexall Health from Katz Group for $2.2 billion, strengthening McKesson's Canadian pharmaceutical supply chain.
Hospital systems that have acquired physician practices and outpatient treatment centers are wrestling with how to integrate them into their existing supply-chain distribution system. The goal is to extend the low prices achieved through bulk purchasing to these geographically dispersed facilities.